OR
RMD icon

Olympiad Research’s ResMed RMD Stock Holding History

Olympiad Research’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,503
Closed -$336K – 274
2025
Q1 		$336K Buy
1,503
+68
+5% +$15.9K 0.39% 56
2024
Q4 		$328K Buy
+1,435
New +$346K 0.34% 83
2024
Q3 		– Sell
-2,339
Closed -$448K – 450
2024
Q2 		$448K Sell
2,339
-943
-29% -$191K 0.33% 73
2024
Q1 		$650K Buy
3,282
+1,517
+86% +$278K 0.43% 38
2023
Q4 		$304K Sell
1,765
-155
-8% -$23.8K 0.24% 158
2023
Q3 		$284K Sell
1,920
-424
-18% -$76.7K 0.28% 133
2023
Q2 		$512K Buy
+2,344
New +$522K 0.5% 40

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Olympiad Research's RMD Position: Q2 2025 in Review

Olympiad Research sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,503 shares — an estimated $336K sold.

Olympiad Research first reported a position in RMD in Q2 2023 and held it in 7 quarters. The position peaked at $650K in Q1 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Olympiad Research reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Olympiad Research sold 1,503 ResMed shares in Q2 2025, an estimated $336K.
  • Olympiad Research first reported a position in ResMed in Q2 2023 and held it in 7 quarters.
  • Olympiad Research's ResMed position peaked at $650K in Q1 2024.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Olympiad Research's 13F filing for Q2 2025, filed 8 Aug 2025.